![6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one structure](/static/products/3843/384364-90-3.webp)
6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one
TL;DR: 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one (CAS 384364-90-3) is a chemical compound with molecular formula C31H40N2O4 and molecular weight 504.30 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenylchromen-4-one
Also Known As: 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one, 6,8-Bis((3,3-dimethylpiperidin-1-yl)methyl)-5,7-dihydroxy-2-phenyl-4H-chromen-4-one, 6,8-bis[(3,3-dimethyl-1-piperidyl)methyl]-5,7-dihydroxy-2-phenyl-chromen-4-one, 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4 h -chromen-4-one, 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenylchromen-4-one
| Molecular Formula | C31H40N2O4 |
|---|---|
| Molecular Weight | 504.30 g/mol |
| LogP | 6.1152 |
| Topological Polar Surface Area | 77.15 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Exact Mass | 504.2988 |
| Heavy Atoms | 37 |
| Complexity | 1343.0555 |
Chemical Identifiers
| CAS Number | 384364-90-3 |
|---|---|
| SMILES | CC1(CCCN(C1)CC2=C(C(=C3C(=C2O)C(=O)C=C(O3)C4=CC=CC=C4)CN5CCCC(C5)(C)C)O)C |
Product Overview
6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one (CAS 384364-90-3), with molecular formula C31H40N2O4 and molecular weight 504.30 g/mol. IUPAC: 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenylchromen-4-one.
Chemical Property Profile of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one
Property Insights of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one
The XLogP value of 6.1152 indicates that 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 77.15 Ų falls within the moderate polarity range, balancing permeability and solubility for 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one. Following Lipinski's Rule of Five, 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one has 2 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one?
The CAS number of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one is 384364-90-3.
What is the molecular formula of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one?
The molecular formula of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one is C31H40N2O4.
What is the molecular weight of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one?
The molecular weight of 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one is 504.30 g/mol.
Where can I buy 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one?
You can request a quote for 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one?
Yes, KEHONG BIO provides custom synthesis services for 6,8-bis[(3,3-dimethylpiperidin-1-yl)methyl]-5,7-dihydroxy-2-phenyl-4H-chromen-4-one and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.